762286-09-9

Basic information

• Product Name: Carbamic acid, [[4,4-dimethyl-1-[(3R)-3-(methylamino)-1-pyrrolidinyl]cyclohexyl]methyl]-, 1,1-dimethylethyl ester
• CAS NO: 762286-09-9
• Molecular Formula: C19H37N3O2
• Molecular Weight: 339.522
• Mol File: 762286-09-9.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: Carbamic acid, [[4,4-dimethyl-1-[(3R)-3-(methylamino)-1-pyrrolidinyl]cyclohexyl]methyl]-, 1,1-dimethylethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Carbamic acid, [[4,4-dimethyl-1-[(3R)-3-(methylamino)-1-pyrrolidinyl]cyclohexyl]methyl]-, 1,1-dimethylethyl ester(762286-09-9)
• EPA Substance Registry System: Carbamic acid, [[4,4-dimethyl-1-[(3R)-3-(methylamino)-1-pyrrolidinyl]cyclohexyl]methyl]-, 1,1-dimethylethyl ester(762286-09-9)

Safety Data

• Hazardous Substances Data: 762286-09-9(Hazardous Substances Data)

Upstream product

• 762286-08-8 C₁₈H₃₄N₂O₃ 
• 74-89-5 methylamine 

Relevant articles and documents

MELANIN-CONCENTRATING HORMONE RECEPTOR ANTAGONISTS AND COMPOSITIONS AND METHODS RELATED THERETO

Melanin-concentrating hormone (MCH) receptor antagonists are disclosed having utility for the treatment of MCH receptor-based disorders such as obesity. The compounds of this invention have the following structure: including stereoisomers, prodrugs, and pharmaceutically acceptable salts thereof, wherein m, n, X, R1, R2, R3, R4, and R5 are as defined herein. Also disclosed are compositions containing a compound of this invention, as well as methods relating to the use thereof.